Our clinical trials information service turns 3 this week - and what a busy 3 years it has been!
Phase 3 study reports better outcomes.
Results of a phase 3 trial for people with CLL with other medical conditions
AstraZeneca announced interim results from their phase 3 ASCEND trial at the European Hematology Association Congress #EHA24 last month
The Lancet Oncology has recently published results of a phase 1 trial of a potential new treatment for T-cell skin lymphoma
Here we summarise some of the latest lymphoma research presented at the American Society of Clinical Oncology's annual meeting in Chicago in June.
Phase 2 study finds that a new treatment combination may improve outcomes for people with relapsed or refractory Hodgkin lymphoma.
Recognising the importance of clinical trials and thanking all those involved
Two recent studies have looked at whether the particular molecular subtype of DLBCL can be used to tailor a person's treatment.
A recent clinical trial found that giving two additional doses of rituximab to people with aggressive B-cell lymphoma who responded to six cycles of R-CHOP did not improve outcomes.